Detalhe da pesquisa
1.
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 116-125.e5, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039585
2.
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
Am J Clin Dermatol
; 25(1): 127-138, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624488
3.
Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and α2δ ligands.
Eur Neurol
; 66(1): 18-29, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21709418
4.
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies.
Inflamm Bowel Dis
; 27(7): 983-993, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32794567
5.
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
Inflamm Bowel Dis
; 27(6): 816-825, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766762
6.
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme.
J Crohns Colitis
; 15(6): 914-929, 2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33245746
7.
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program.
Am J Clin Dermatol
; 22(5): 693-707, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406619
8.
Oxadiazolone bioisosteres of pregabalin and gabapentin.
Bioorg Med Chem Lett
; 19(1): 247-50, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19010672
9.
Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks.
Learn Mem
; 15(11): 806-9, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957525
10.
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
Inflamm Bowel Dis
; 24(10): 2258-2265, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29850873
11.
The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific.
Psychopharmacology (Berl)
; 191(2): 223-31, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17211653
12.
Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program.
Am J Clin Dermatol
; 22(6): 905, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642878
13.
Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.
J Med Chem
; 48(7): 2294-307, 2005 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-15801823
14.
Novel cyclopropyl beta-amino acid analogues of pregabalin and gabapentin that target the alpha2-delta protein.
J Med Chem
; 48(8): 3026-35, 2005 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-15828841
15.
The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?
Trends Pharmacol Sci
; 34(6): 332-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23642658
16.
Modern Methods of Monosaccharide Synthesis from Non-Carbohydrate Sources.
Chem Rev
; 96(3): 1195-1220, 1996 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-11848785
17.
The alpha2-delta protein: an auxiliary subunit of voltage-dependent calcium channels as a recognized drug target.
Curr Opin Investig Drugs
; 11(7): 761-70, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20571971
18.
FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Neuropsychopharmacology
; 35(8): 1775-87, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20357755
19.
Biocatalytic Syntheses of Protected D-Mannose-d(5), D-Mannose-d(7), D-Mannitol-2,3,4,5,6-d(5), and D-Mannitol-1,1,2,3,4,5,6,6-d(8).
J Org Chem
; 61(12): 4151-4153, 1996 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-11667298
20.
Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
Neuropsychopharmacology
; 34(9): 2072-80, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19322169